Pharma & Biotech
Pine will work to develop the company’s product portfolio in both the US and Canada
09.32 Fri 25 Sep 2020
Dyadic on course to disrupt the status quo in manufacturing biologic vaccines and drugs
TRACON Pharmaceuticals driving the development of targeted therapies for cancer
Kazia Therapeutics to share pipeline results with market and clinicians
Only registered members can use this feature.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.